Related Articles
Long‑term complete response in a patient with postoperative recurrent ALK‑rearranged lung adenocarcinoma treated with crizotinib: A case report
ALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report
Neuroendocrine carcinoma of the lung expressing anaplastic lymphoma kinase on high‑sensitivity immunohistochemistry: A case report
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
Primary signet‑ring cell carcinoma of the lung treated with crizotinib: A case report